NCT02048670

Brief Summary

Researchers are gathering information on the safety and effectiveness of a new device called the BalanceBelt.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2014

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 22, 2014

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 29, 2014

Completed
8 months until next milestone

Study Start

First participant enrolled

October 1, 2014

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2017

Completed
1.9 years until next milestone

Results Posted

Study results publicly available

May 15, 2019

Completed
Last Updated

May 15, 2019

Status Verified

April 1, 2019

Enrollment Period

2.8 years

First QC Date

January 22, 2014

Results QC Date

April 24, 2019

Last Update Submit

April 24, 2019

Conditions

Keywords

Pilot studyAssessment of sway phaseTherapy trial phase

Outcome Measures

Primary Outcomes (1)

  • Degrees of Sway

    The Sensory Organization Test is a six condition standard evaluation of balance control performed on a dynamic platform that can record sway movement in the A/P dimension while the sensory inputs from proprioception and vision are varied though the platform and visual surround movements. Condition 1 - eyes open, visual locked, platform locked. Condition 2 - eyes closed, visual locked, platform locked. Condition 3 - eyes open, visual unlocked, platform locked. Condition 4 - eyes open, visual locked, platform unlocked. Condition 5 - eyes closed, visual locked, platform unlocked. Condition 6 - eyes open, visual unlocked, platform unlocked. All participants progress though the exam, starting with condition 1 and ending with condition 6. All conditions were completed two to three times depending on performance with the average of each condition reported.

    baseline

Secondary Outcomes (1)

  • Visual Analog Scales Score

    baseline

Study Arms (2)

Chronic Subjective Dizziness Syndrome Subjects

EXPERIMENTAL

Subjects diagnosed with Chronic Subjective Dizziness Syndrome (CDS) will wear the BalanceBelt while performing test involving walking and balance.

Device: Balance Belt

Healthy Subjects

ACTIVE COMPARATOR

Age matched healthy subjects without complaints of balance or dizziness problems will wear the BalanceBelt while performing test involving walking and balance.

Device: Balance Belt

Interventions

Vestibular habituation therapy worn under the clothes around the waist that uses sensitive motion detectors and vibrates against the skin at four locations to provide information about posture and gait

Also known as: Stabalon Belt, Vibrating Belt
Chronic Subjective Dizziness Syndrome SubjectsHealthy Subjects

Eligibility Criteria

Age25 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects will be 25-70 years of age inclusive and pregnant women may participate.
  • Patients will have CSD as their primary diagnosis for the cause of their balance and dizziness complaints provided by the Behavioral Medicine Program for Dizziness, a division of the Department of Psychiatry \& Psychology.
  • Normal volunteers will have a negative history of otologic \& neurologic disorders and no history of dizziness and balance problems.
  • Normal volunteers will have normal findings on a screening office examination for peripheral and central vestibular system involvement (see methods for details of the examination) and screening for normal or symmetrical hearing loss of explainable origin.

You may not qualify if:

  • Patients with positive indications from testing of peripheral and/or central vestibular system involvement that is felt to be influencing the symptoms reported beyond the CSD alone.
  • Patients with mobility restriction that would prevent participating in the tests or the intensive therapy trials.
  • Subjects with hearing impairment that interferes with oral communication.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic

Rochester, Minnesota, 55905, United States

Location

Related Links

Results Point of Contact

Title
Dr. Devin L. McCaslin
Organization
Mayo Clinic

Study Officials

  • Jeffrey Staab, MD

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PI

Study Record Dates

First Submitted

January 22, 2014

First Posted

January 29, 2014

Study Start

October 1, 2014

Primary Completion

July 1, 2017

Study Completion

July 1, 2017

Last Updated

May 15, 2019

Results First Posted

May 15, 2019

Record last verified: 2019-04

Data Sharing

IPD Sharing
Will not share

Locations